Cargando…
Immunoglobin G/total antibody testing for SARS-CoV-2: A prospective cohort study of ambulatory patients and health care workers in two Belgian oncology units comparing three commercial tests
BACKGROUND: Coronavirus disease (COVID-19) is interfering heavily with the screening, diagnosis and treatment of cancer patients. Better knowledge of the seroprevalence and immune response after Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection in this population is important to...
Autores principales: | van Dam, Peter, Huizing, Manon, Roelant, Ella, Hotterbeekx, An, De Winter, Fien H.R., Kumar-Singh, Samir, Moons, Pieter, Amajoud, Zainab, Vulsteke, Christof, Croes, Lieselot, Janssens, Annelies, Berneman, Zwi, Prenen, Hans, Meuris, Leander, Vanden Berghe, Wim, Smits, Evelien, Peeters, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914028/ https://www.ncbi.nlm.nih.gov/pubmed/33773276 http://dx.doi.org/10.1016/j.ejca.2021.02.024 |
Ejemplares similares
-
Blood Cytokine Analysis Suggests That SARS-CoV-2 Infection Results in a Sustained Tumour Promoting Environment in Cancer Patients
por: De Winter, Fien H. R., et al.
Publicado: (2021) -
SARS-CoV-2 and cancer: Are they really partners in crime?
por: van Dam, Peter A., et al.
Publicado: (2020) -
36P Alterations in tumour-promoting cytokines in cancer patients after SARS-CoV-2 infection
por: De Winter, F.H., et al.
Publicado: (2021) -
Ipilimumab- and nivolumab-induced myocarditis in a patient with metastatic cholangiocarcinoma: a case report
por: Delombaerde, Danielle, et al.
Publicado: (2022) -
Prescreening for COVID-19 in patients receiving cancer treatment using a patient-reported outcome platform
por: Peeters, Marc, et al.
Publicado: (2020)